VAXON BIOTECH
VAXON BIOTECH Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20120082692 | Identification, Optimization and Use of Cryptic HLA-A24 Epitopes for Immunotherapy - The present invention pertains to methods for identifying a HLA-A*2402-restricted cryptic epitope in an antigen, and for increasing its immunogenicity, in order to obtain HLA-A*2402-restricted epitopes able to trigger an immune response against HLA-A*2402-restricted cryptic epitopes. Isolated peptides consisting of cryptic or optimized HLA-A*2402-restricted epitopes are provided. | 04-05-2012 |